GlaxoSmithKline, Merck KGaA officially call it quits on $4B partnership for flailing cancer drug - Endpoints News

1. GlaxoSmithKline, Merck KGaA officially call it quits on $4B partnership for flailing cancer drug  Endpoints News
2. Merck to buy Acceleron for about $11.5 billion in rare-disease drugs push  CNBC
3. Merck to acquire Acceleron Pharma in $11.5 billion deal  CNBC Television
4. Merck to Buy Rare-Disease Firm Acceleron for $11.5 Billion  Yahoo Finance
5. Merck buying Acceleron Pharma in $11.5B deal  Fox Business
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/3kWPqdT